SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-16-000169
Filing Date
2016-05-13
Accepted
2016-05-13 16:14:17
Documents
3
Period of Report
2016-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201605098-k.htm 8-K 31630
2 EXHIBIT 10.1 mhahnamendment.htm EX-10.1 9850
3 companylogo.gif GRAPHIC 2462
  Complete submission text file 0001615219-16-000169.txt   46278
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 161648529
SIC: 2834 Pharmaceutical Preparations